TreeWAS – Variant ID: rs11995572

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
H40.2 Primary angle-closure glaucoma	0.000	0.677	0.323
H40 Glaucoma	0.000	0.714	0.286
H40.1 Primary open-angle glaucoma	0.000	0.724	0.276
H40.5 Glaucoma secondary to other eye disorders	0.000	0.730	0.270
H40.4 Glaucoma secondary to eye inflammation	0.000	0.781	0.219
H40.3 Glaucoma secondary to eye trauma	0.000	0.794	0.206
H40.6 Glaucoma secondary to drugs	0.000	0.795	0.205
I70-I79 Diseases of arteries, arterioles and capillaries	0.000	0.836	0.164
I78.1 Naevus, nonneoplastic	0.000	0.837	0.163
I78 Diseases of capillaries	0.000	0.837	0.163
I71 Aortic aneurysm and dissection	0.000	0.839	0.161
I77.1 Stricture of artery	0.000	0.841	0.159
I77 Other disorders of arteries and arterioles	0.000	0.841	0.159
I71.0 Dissection of aorta [any part]	0.000	0.846	0.154
H40.8 Other glaucoma	0.000	0.851	0.149
I71.2 Thoracic aortic aneurysm, without mention of rupture	0.000	0.857	0.143
I74 Arterial embolism and thrombosis	0.000	0.859	0.141
I70 Atherosclerosis	0.000	0.863	0.137
I71.3 Abdominal aortic aneurysm, ruptured	0.000	0.865	0.135
I78.0 Hereditary haemorrhagic telangiectasia	0.000	0.869	0.131
H40.0 Glaucoma suspect	0.000	0.870	0.130
I74.5 Embolism and thrombosis of iliac artery	0.000	0.870	0.130
H40.9 Glaucoma, unspecified	0.000	0.872	0.128
I77.9 Disorder of arteries and arterioles, unspecified	0.000	0.874	0.126
I74.9 Embolism and thrombosis of unspecified artery	0.000	0.877	0.123
H40-H42 Glaucoma	0.000	0.880	0.120
I70.2 Atherosclerosis of arteries of the extremities	0.000	0.881	0.119
I78.9 Disease of capillaries, unspecified	0.000	0.883	0.117
I77.8 Other specified disorders of arteries and arterioles	0.000	0.883	0.117
I71.8 Aortic aneurysm of unspecified site, ruptured	0.000	0.884	0.116
I71.6 Thoracoabdominal aortic aneurysm, without mention of rupture	0.000	0.884	0.116
I71.5 Thoracoabdominal aortic aneurysm, ruptured	0.000	0.884	0.116
I71.1 Thoracic aortic aneurysm, ruptured	0.000	0.884	0.116
I77.5 Necrosis of artery	0.000	0.886	0.114
I77.4 Coeliac artery compression syndrome	0.000	0.886	0.114
I77.3 Arterial fibromuscular dysplasia	0.000	0.886	0.114
I71.4 Abdominal aortic aneurysm, without mention of rupture	0.000	0.887	0.113
I73 Other peripheral vascular diseases	0.000	0.887	0.113
I77.0 Arteriovenous fistula, acquired	0.000	0.893	0.107
I74.2 Embolism and thrombosis of arteries of the upper extremities	0.000	0.893	0.107
I70.20 Atherosclerosis of arteries of extremities (without gangrene)	0.000	0.896	0.104
I74.1 Embolism and thrombosis of other and unspecified parts of aorta	0.000	0.897	0.103
I74.0 Embolism and thrombosis of abdominal aorta	0.000	0.898	0.101
I77.2 Rupture of artery	0.000	0.899	0.101
I73.9 Peripheral vascular disease, unspecified	0.000	0.899	0.101
I78.8 Other diseases of capillaries	0.000	0.900	0.100
I79 Disorders of arteries, arterioles and capillaries in diseases classified elsewhere	0.000	0.900	0.100
I70.1 Atherosclerosis of renal artery	0.000	0.901	0.099
I70.9 Generalised and unspecified atherosclerosis	0.000	0.902	0.098
I70.8 Atherosclerosis of other arteries	0.000	0.902	0.098
I70.0 Atherosclerosis of aorta	0.000	0.905	0.095
I71.9 Aortic aneurysm of unspecified site, without mention of rupture	0.000	0.906	0.094
I70.21 Atherosclerosis of arteries of extremities (with gangrene)	0.000	0.911	0.089
H42 Glaucoma in diseases classified elsewhere	0.000	0.914	0.086
I74.3 Embolism and thrombosis of arteries of the lower extremities	0.000	0.917	0.083
I74.4 Embolism and thrombosis of arteries of extremities, unspecified	0.000	0.918	0.081
I73.8 Other specified peripheral vascular diseases	0.000	0.919	0.081
I73.1 Thromboangiitis obliterans [Buerger]	0.000	0.919	0.081
I77.6 Arteritis, unspecified	0.000	0.920	0.080
I72 Other aneurysm	0.000	0.921	0.079
I74.8 Embolism and thrombosis of other arteries	0.000	0.923	0.077
I70.10 Atherosclerosis of renal artery (without gangrene)	0.000	0.928	0.072
I79.8 Other disorders of arteries, arterioles and capillaries in diseases classified elsewhere	0.000	0.928	0.072
I79.1 Aortitis in diseases classified elsewhere	0.000	0.928	0.072
I79.0 Aneurysm of aorta in diseases classified elsewhere	0.000	0.928	0.072
I70.11 Atherosclerosis of renal artery (with gangrene)	0.000	0.929	0.071
I70.81 Atherosclerosis of other arteries (with gangrene)	0.000	0.929	0.071
I70.80 Atherosclerosis of other arteries (without gangrene)	0.000	0.929	0.071
I70.91 Generalized and unspecified atherosclerosis (with gangrene)	0.000	0.929	0.071
I70.90 Generalized and unspecified atherosclerosis (without gangrene)	0.000	0.929	0.071
I70.01 Atherosclerosis of aorta (with gangrene)	0.000	0.931	0.068
I70.00 Atherosclerosis of aorta (without gangrene)	0.000	0.934	0.065
I72.3 Aneurysm of iliac artery	0.000	0.936	0.064
H42.8 Glaucoma in other diseases classified elsewhere	0.000	0.938	0.062
H42.0 Glaucoma in endocrine, nutritional and metabolic diseases	0.000	0.938	0.062
I72.8 Aneurysm of other specified arteries	0.000	0.942	0.058
I72.6 Aneurysm and dissection of vertebral artery	0.000	0.943	0.057
I72.5 Aneurysm and dissection of other precerebral arteries	0.000	0.943	0.057
I72.1 Aneurysm of artery of upper extremity	0.000	0.943	0.057
I72.2 Aneurysm of renal artery	0.000	0.945	0.055
I79.2 Peripheral angiopathy in diseases classified elsewhere	0.000	0.946	0.054
I72.9 Aneurysm of unspecified site	0.000	0.950	0.050
B37.0 Candidal stomatitis	0.049	0.951	0.000
I72.0 Aneurysm of carotid artery	0.000	0.956	0.044
I72.4 Aneurysm of artery of lower extremity	0.000	0.961	0.039
N93.9 Abnormal uterine and vaginal bleeding, unspecified	0.000	0.971	0.029
N18.5 Chronic kidney disease, stage 5	0.000	0.979	0.021
M22.4 Chondromalacia patellae	0.000	0.980	0.020
N18.4 Chronic kidney disease, stage 4	0.000	0.981	0.019
T43.2 Other and unspecified antidepressants	0.019	0.981	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.017	0.983	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.017	0.983	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.017	0.983	0.000
I73.0 Raynaud's syndrome	0.000	0.984	0.016
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.016	0.984	0.000
N18 Chronic renal failure	0.000	0.985	0.015
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.015	0.985	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.015	0.985	0.000
T42.1 Iminostilbenes	0.015	0.985	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.015	0.985	0.000
T39.1 4-Aminophenol derivatives	0.014	0.986	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.014	0.986	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.014	0.986	0.000
Z22.3 Carrier of other specified bacterial diseases	0.014	0.986	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.014	0.986	0.000
N18.2 Chronic kidney disease, stage 2	0.000	0.986	0.014
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.014	0.986	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.013	0.987	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.013	0.987	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.013	0.987	0.000
T42.4 Benzodiazepines	0.013	0.987	0.000
T43.6 Psychostimulants with abuse potential	0.013	0.987	0.000
T39.0 Salicylates	0.013	0.987	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.013	0.987	0.000
T43.9 Psychotropic drug, unspecified	0.012	0.987	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.012	0.987	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.012	0.988	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.012	0.988	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.012	0.988	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.012	0.988	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.012	0.988	0.000
T42.3 Barbiturates	0.012	0.988	0.000
T42.2 Succinimides and oxazolidinediones	0.012	0.988	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.012	0.988	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.012	0.988	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.012	0.988	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.011	0.988	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.011	0.988	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.011	0.988	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.011	0.988	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.011	0.988	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.011	0.988	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.011	0.988	0.000
T44.0 Anticholinesterase agents	0.011	0.988	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.011	0.989	0.000
T47.2 Stimulant laxatives	0.011	0.989	0.000
T47.4 Other laxatives	0.011	0.989	0.000
T39.4 Antirheumatics, not elsewhere classified	0.011	0.989	0.000
T39.2 Pyrazolone derivatives	0.011	0.989	0.000
T36 Poisoning by systemic antibiotics	0.011	0.989	0.000
T50.8 Diagnostic agents	0.011	0.989	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.011	0.989	0.000
T45.0 Antiallergic and antiemetic drugs	0.011	0.989	0.000
N18.8 Other chronic renal failure	0.000	0.990	0.010
T50.9 Other and unspecified drugs, medicaments and biological substances	0.010	0.990	0.000
N18.1 Chronic kidney disease, stage 1	0.000	0.990	0.010
T50.4 Drugs affecting uric acid metabolism	0.010	0.990	0.000
T42.0 Hydantoin derivatives	0.010	0.990	0.000
T50.7 Analeptics and opioid receptor antagonists	0.010	0.990	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.010	0.990	0.000
T50.5 Appetite depressants	0.010	0.990	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.010	0.990	0.000
T50.1 Loop [high-ceiling] diuretics	0.010	0.990	0.000
T50.0 Mineralocorticoids and their antagonists	0.010	0.990	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.010	0.990	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.010	0.990	0.000
T47.7 Emetics	0.010	0.990	0.000
T47.6 Antidiarrhoeal drugs	0.010	0.990	0.000
T47.5 Digestants	0.010	0.990	0.000
T47.3 Saline and osmotic laxatives	0.010	0.990	0.000
T47.0 Histamine H(2)-receptor antagonists	0.010	0.990	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.010	0.990	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.010	0.990	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.010	0.990	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.010	0.990	0.000
T37.5 Antiviral drugs	0.010	0.990	0.000
T37.4 Anthelminthics	0.010	0.990	0.000
T37.3 Other antiprotozoal drugs	0.010	0.990	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.010	0.990	0.000
T37.1 Antimycobacterial drugs	0.010	0.990	0.000
T37.0 Sulphonamides	0.010	0.990	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.010	0.990	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.010	0.990	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.010	0.990	0.000
S52.60 Fracture of lower end of both ulna and radius (closed)	0.000	0.990	0.010
T46.1 Calcium-channel blockers	0.009	0.990	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.009	0.991	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.009	0.991	0.000
T46.7 Peripheral vasodilators	0.009	0.991	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.009	0.991	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.009	0.991	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.009	0.991	0.000
T41.5 Therapeutic gases	0.009	0.991	0.000
T41.4 Anaesthetic, unspecified	0.009	0.991	0.000
T41.3 Local anaesthetics	0.009	0.991	0.000
T41.2 Other and unspecified general anaesthetics	0.009	0.991	0.000
T41.1 Intravenous anaesthetics	0.009	0.991	0.000
T41.0 Inhaled anaesthetics	0.009	0.991	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.009	0.991	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.009	0.991	0.000
T48.5 Anti-common-cold drugs	0.009	0.991	0.000
T48.4 Expectorants	0.009	0.991	0.000
T48.3 Antitussives	0.009	0.991	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.009	0.991	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.009	0.991	0.000
T48.0 Oxytocic drugs	0.009	0.991	0.000
T49.9 Topical agent, unspecified	0.009	0.991	0.000
T49.8 Other topical agents	0.009	0.991	0.000
T49.7 Dental drugs, topically applied	0.009	0.991	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.009	0.991	0.000
T49.5 Ophthalmological drugs and preparations	0.009	0.991	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.009	0.991	0.000
T49.3 Emollients, demulcents and protectants	0.009	0.991	0.000
T49.2 Local astringents and local detergents	0.009	0.991	0.000
T49.1 Antipruritics	0.009	0.991	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.009	0.991	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.009	0.991	0.000
T45.8 Other primarily systemic and haematological agents	0.009	0.991	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.009	0.991	0.000
T45.6 Fibrinolysis-affecting drugs	0.009	0.991	0.000
T45.4 Iron and its compounds	0.009	0.991	0.000
T45.3 Enzymes, not elsewhere classified	0.009	0.991	0.000
T38.9 Other and unspecified hormone antagonists	0.009	0.991	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.009	0.991	0.000
T38.7 Androgens and anabolic congeners	0.009	0.991	0.000
T38.5 Other oestrogens and progestogens	0.009	0.991	0.000
T38.4 Oral contraceptives	0.009	0.991	0.000
T38.2 Antithyroid drugs	0.009	0.991	0.000
T38.0 Glucocorticoids and synthetic analogues	0.009	0.991	0.000
B37 Candidiasis	0.009	0.991	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.008	0.991	0.000
N18.0 End-stage renal disease	0.000	0.992	0.008
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.008	0.992	0.000
T45.5 Anticoagulants	0.008	0.992	0.000
T45.2 Vitamins, not elsewhere classified	0.008	0.992	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.008	0.992	0.000
Z02.8 Other examinations for administrative purposes	0.008	0.992	0.000
T38.1 Thyroid hormones and substitutes	0.008	0.992	0.000
T36.9 Systemic antibiotic, unspecified	0.008	0.992	0.000
T36.8 Other systemic antibiotics	0.008	0.992	0.000
T36.7 Antifungal antibiotics, systemically used	0.008	0.992	0.000
T36.6 Rifamycins	0.008	0.992	0.000
T36.5 Aminoglycosides	0.008	0.992	0.000
T36.4 Tetracyclines	0.008	0.992	0.000
T36.3 Macrolides	0.008	0.992	0.000
T36.2 Chloramphenicol group	0.008	0.992	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.008	0.992	0.000
S52.6 Fracture of lower end of both ulna and radius	0.000	0.992	0.008
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.008	0.992	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.007	0.992	0.000
M22 Disorders of patella	0.000	0.993	0.007
T43.0 Tricyclic and tetracyclic antidepressants	0.007	0.993	0.000
B37.1 Pulmonary candidiasis	0.007	0.993	0.000
N18.9 Chronic renal failure, unspecified	0.000	0.993	0.007
I83.9 Varicose veins of lower extremities without ulcer or inflammation	0.000	0.993	0.007
Z22 Carrier of infectious disease	0.007	0.993	0.000
C92.0 Acute myeloid leukaemia	0.000	0.993	0.007
B37.7 Candidal septicaemia	0.006	0.993	0.000
B37.6 Candidal endocarditis	0.006	0.993	0.000
B37.5 Candidal meningitis	0.006	0.993	0.000
R30.0 Dysuria	0.006	0.994	0.000
S52.61 Fracture of lower end of both ulna and radius (open)	0.000	0.994	0.006
S52.00 Fracture of upper end of ulna (closed)	0.000	0.994	0.006
M22.8 Other disorders of patella	0.000	0.994	0.006
T36.0 Penicillins	0.006	0.994	0.000
S52.0 Fracture of upper end of ulna	0.000	0.994	0.006
N93 Other abnormal uterine and vaginal bleeding	0.000	0.994	0.006
B37.4 Candidiasis of other urogenital sites	0.006	0.994	0.000
Y40.0 Penicillins	0.000	0.994	0.006
S52 Fracture of forearm	0.000	0.994	0.006
O42.9 Premature rupture of membranes, unspecified	0.006	0.994	0.000
S02.60 Fracture of mandible (closed)	0.000	0.994	0.006
B37.2 Candidiasis of skin and nail	0.006	0.994	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.006	0.994	0.000
T40.8 Lysergide [LSD]	0.006	0.994	0.000
T40.7 Cannabis (derivatives)	0.006	0.994	0.000
T40.5 Cocaine	0.006	0.994	0.000
T40.3 Methadone	0.006	0.994	0.000
T40.1 Heroin	0.006	0.994	0.000
T40.0 Opium	0.006	0.994	0.000
B37.9 Candidiasis, unspecified	0.006	0.994	0.000
D61.9 Aplastic anaemia, unspecified	0.000	0.994	0.006
M22.2 Patellofemoral disorders	0.000	0.994	0.006
M22.1 Recurrent subluxation of patella	0.000	0.995	0.005
M22.9 Disorder of patella, unspecified	0.000	0.995	0.005
S52.1 Fracture of upper end of radius	0.000	0.995	0.005
B37.3 Candidiasis of vulva and vagina	0.005	0.995	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.005	0.995	0.000
B07 Viral warts	0.000	0.995	0.005
T40.4 Other synthetic narcotics	0.005	0.995	0.000
S52.01 Fracture of upper end of ulna (open)	0.000	0.995	0.005
Z22.9 Carrier of infectious disease, unspecified	0.005	0.995	0.000
Z22.6 Carrier of human T-lymphotropic virus type 1 [HTLV-1] infection	0.005	0.995	0.000
Z22.4 Carrier of infections with a predominantly sexual mode of transmission	0.005	0.995	0.000
Z22.2 Carrier of diphtheria	0.005	0.995	0.000
Z22.0 Carrier of typhoid	0.005	0.995	0.000
S52.10 Fracture of upper end of radius (closed)	0.000	0.995	0.005
Y40.9 Systemic antibiotic, unspecified	0.000	0.995	0.005
Y40 Systemic antibiotics	0.000	0.995	0.005
Z22.8 Carrier of other infectious diseases	0.005	0.995	0.000
M22.0 Recurrent dislocation of patella	0.000	0.995	0.005
Z22.1 Carrier of other intestinal infectious diseases	0.005	0.995	0.000
T40.6 Other and unspecified narcotics	0.005	0.995	0.000
S52.8 Fracture of other parts of forearm	0.000	0.995	0.005
Y40.1 Cefalosporins and other -lactam antibiotics	0.000	0.995	0.005
Y40.8 Other systemic antibiotics	0.000	0.995	0.004
B37.8 Candidiasis of other sites	0.005	0.995	0.000
Y40.3 Macrolides	0.000	0.996	0.004
K76.8 Other specified diseases of liver	0.004	0.996	0.000
S52.9 Fracture of forearm, part unspecified	0.000	0.996	0.004
Z21 Asymptomatic human immunodeficiency virus [HIV] infection status	0.004	0.996	0.000
N93.8 Other specified abnormal uterine and vaginal bleeding	0.000	0.996	0.004
M22.10 Recurrent subluxation of patella, unspecified knee	0.000	0.996	0.004
Z20-Z29 Persons with potential health hazards related to communicable diseases	0.004	0.996	0.000
G55.1 Nerve root and plexus compressions in intervertebral disk disorders	0.004	0.996	0.000
S52.2 Fracture of shaft of ulna	0.000	0.996	0.004
S52.11 Fracture of upper end of radius (open)	0.000	0.996	0.004
S52.4 Fracture of shafts of both ulna and radius	0.000	0.996	0.004
S52.7 Multiple fractures of forearm	0.000	0.996	0.004
S52.3 Fracture of shaft of radius	0.000	0.996	0.004
Y40.4 Tetracyclines	0.000	0.996	0.004
Y40.2 Chloramphenicol group	0.000	0.996	0.004
Y40.5 Aminoglycosides	0.000	0.996	0.004
D12.0 Caecum	0.004	0.996	0.000
S52.80 Fracture of other parts of forearm (closed)	0.000	0.996	0.004
M22.3 Other derangements of patella	0.000	0.996	0.003
Z22.5 Carrier of viral hepatitis	0.004	0.996	0.000
S52.81 Fracture of other parts of forearm (open)	0.000	0.996	0.003
Y40.7 Antifungal antibiotics, systemically used	0.000	0.996	0.003
Y40.6 Rifamycins	0.000	0.996	0.003
Z24 Need for immunisation against certain single viral diseases	0.003	0.996	0.000
Z75.1 Person awaiting admission to adequate facility elsewhere	0.004	0.996	0.000
Z02 Examination and encounter for administrative purposes	0.003	0.997	0.000
S52.91 Fracture of forearm, part unspecified (open)	0.000	0.997	0.003
S52.90 Fracture of forearm, part unspecified (closed)	0.000	0.997	0.003
N48.6 Balanitis xerotica obliterans	0.003	0.997	0.000
S52.40 Fracture of shafts of both ulna and radius (closed)	0.000	0.997	0.003
T40.2 Other opioids	0.003	0.997	0.000
H54.7 Unspecified visual loss	0.003	0.997	0.000
Z28 Immunisation not carried out	0.003	0.997	0.000
Z27 Need for immunisation against combinations of infectious diseases	0.003	0.997	0.000
Z26 Need for immunisation against other single infectious diseases	0.003	0.997	0.000
Z25 Need for immunisation against other single viral diseases	0.003	0.997	0.000
Z23 Need for immunisation against single bacterial diseases	0.003	0.997	0.000
Z20 Contact with and exposure to communicable diseases	0.003	0.997	0.000
M23.36 Other meniscus derangements (Other and unspecified lateral meniscus)	0.003	0.997	0.000
I83 Varicose veins of lower extremities	0.000	0.997	0.003
S52.21 Fracture of shaft of ulna (open)	0.000	0.997	0.003
S02.6 Fracture of mandible	0.000	0.997	0.003
S52.71 Multiple fractures of forearm (open)	0.000	0.997	0.003
Z49.0 Preparatory care for dialysis	0.000	0.997	0.003
Q61.3 Polycystic kidney, unspecified	0.003	0.997	0.000
S52.5 Fracture of lower end of radius	0.000	0.997	0.003
Q61.9 Cystic kidney disease, unspecified	0.003	0.997	0.000
S52.31 Fracture of shaft of radius (open)	0.000	0.997	0.003
D12.5 Sigmoid colon	0.003	0.997	0.000
O03.9 Complete or unspecified, without complication	0.003	0.997	0.000
N88.2 Stricture and stenosis of cervix uteri	0.003	0.997	0.000
Z24.5 Need for immunisation against rubella alone	0.003	0.997	0.000
M89.97 Disorder of bone, unspecified (Ankle and foot)	0.003	0.997	0.000
Q61.2 Polycystic kidney, adult type	0.003	0.997	0.000
Q61 Cystic kidney disease	0.003	0.997	0.000
S52.20 Fracture of shaft of ulna (closed)	0.000	0.997	0.003
Z49.1 Extracorporeal dialysis	0.000	0.997	0.003
C92 Myeloid leukaemia	0.000	0.997	0.003
S52.70 Multiple fractures of forearm (closed)	0.000	0.997	0.003
Z24.6 Need for immunisation against viral hepatitis	0.003	0.997	0.000
Z24.4 Need for immunisation against measles alone	0.003	0.997	0.000
Z24.3 Need for immunisation against yellow fever	0.003	0.997	0.000
Z24.2 Need for immunisation against rabies	0.003	0.997	0.000
Z24.1 Need for immunisation against arthropod-borne viral encephalitis	0.003	0.997	0.000
Z24.0 Need for immunisation against poliomyelitis	0.003	0.997	0.000
I83.2 Varicose veins of lower extremities with both ulcer and inflammation	0.000	0.997	0.003
M89.94 Disorder of bone, unspecified (Hand)	0.003	0.997	0.000
Z02.9 Examination for administrative purposes, unspecified	0.003	0.997	0.000
Z02.7 Issue of medical certificate	0.003	0.997	0.000
Z02.6 Examination for insurance purposes	0.003	0.997	0.000
Z02.5 Examination for participation in sport	0.003	0.997	0.000
Z02.4 Examination for driving licence	0.003	0.997	0.000
Z02.3 Examination for recruitment to armed forces	0.003	0.997	0.000
Z02.2 Examination for admission to residential institution	0.003	0.997	0.000
Z02.1 Pre-employment examination	0.003	0.997	0.000
Z02.0 Examination for admission to educational institution	0.003	0.997	0.000
H26.4 After-cataract	0.000	0.997	0.003
S52.30 Fracture of shaft of radius (closed)	0.000	0.997	0.002
D61 Other aplastic anaemias	0.000	0.997	0.003
S02.80 Fractures of other skull and facial bones (closed)	0.000	0.997	0.003
M89.9 Disorder of bone, unspecified	0.003	0.997	0.000
Z11.0 Special screening examination for intestinal infectious diseases	0.003	0.997	0.000
S52.41 Fracture of shafts of both ulna and radius (open)	0.000	0.997	0.002
Z20.9 Contact with and exposure to unspecified communicable disease	0.002	0.997	0.000
Z20.8 Contact with and exposure to other communicable diseases	0.002	0.997	0.000
Z20.7 Contact with and exposure to pediculosis, acariasis and other infestations	0.002	0.997	0.000
Z20.6 Contact with and exposure to human immunodeficiency virus [HIV]	0.002	0.997	0.000
Z20.5 Contact with and exposure to viral hepatitis	0.002	0.997	0.000
Z20.4 Contact with and exposure to rubella	0.002	0.997	0.000
Z20.3 Contact with and exposure to rabies	0.002	0.997	0.000
Z20.2 Contact with and exposure to infections with a predominantly sexual mode of transmission	0.002	0.997	0.000
Z20.1 Contact with and exposure to tuberculosis	0.002	0.997	0.000
Z20.0 Contact with and exposure to intestinal infectious diseases	0.002	0.997	0.000
Z23.8 Need for immunisation against other single bacterial diseases	0.002	0.997	0.000
Z23.7 Need for immunisation against pertussis alone	0.002	0.997	0.000
Z23.6 Need for immunisation against diphtheria alone	0.002	0.997	0.000
Z23.5 Need for immunisation against tetanus alone	0.002	0.997	0.000
Z23.4 Need for immunisation against tularaemia	0.002	0.997	0.000
Z23.3 Need for immunisation against plague	0.002	0.997	0.000
Z23.2 Need for immunisation against tuberculosis [BCG]	0.002	0.997	0.000
Z23.1 Need for immunisation against typhoid-paratyphoid alone [TAB]	0.002	0.997	0.000
Z23.0 Need for immunisation against cholera alone	0.002	0.997	0.000
Z25.8 Need for immunisation against other specified single viral diseases	0.002	0.997	0.000
Z25.1 Need for immunisation against influenza	0.002	0.997	0.000
Z25.0 Need for immunisation against mumps alone	0.002	0.997	0.000
Z26.9 Need for immunisation against unspecified infectious disease	0.002	0.997	0.000
Z26.8 Need for immunisation against other specified single infectious diseases	0.002	0.997	0.000
Z26.0 Need for immunisation against leishmaniasis	0.002	0.997	0.000
Z27.9 Need for immunisation against unspecified combinations of infectious diseases	0.002	0.997	0.000
Z27.8 Need for immunisation against other combinations of infectious diseases	0.002	0.997	0.000
Z27.4 Need for immunisation against measles-mumps-rubella [MMR]	0.002	0.997	0.000
Z27.3 Need for immunisation against diphtheria-tetanus-pertussis with poliomyelitis [DTP + polio]	0.002	0.997	0.000
Z27.2 Need for immunisation against diphtheria-tetanus-pertussis with typhoid-paratyphoid [DTP + TAB]	0.002	0.997	0.000
Z27.1 Need for immunisation against diphtheria-tetanus-pertussis, combined [DTP]	0.002	0.997	0.000
Z27.0 Need for immunisation against cholera with typhoid-paratyphoid [cholera + TAB]	0.002	0.997	0.000
Z28.9 Immunisation not carried out for unspecified reason	0.002	0.997	0.000
Z28.8 Immunisation not carried out for other reasons	0.002	0.997	0.000
Z28.2 Immunisation not carried out because of patient's decision for other and unspecified reasons	0.002	0.997	0.000
Z28.1 Immunisation not carried out because of patient's decision for reasons of belief or group pressure	0.002	0.997	0.000
Z28.0 Immunisation not carried out because of contraindication	0.002	0.997	0.000
S02.61 Fracture of mandible (open)	0.000	0.997	0.002
I83.1 Varicose veins of lower extremities with inflammation	0.000	0.997	0.003
K63.5 Polyp of colon	0.003	0.997	0.000
S52.51 Fracture of lower end of radius (open)	0.000	0.997	0.002
Z29.1 Prophylactic immunotherapy	0.003	0.997	0.000
Z29 Need for other prophylactic measures	0.002	0.997	0.000
C71.9 Brain, unspecified	0.002	0.998	0.000
Z49 Care involving dialysis	0.000	0.998	0.002
J06.9 Acute upper respiratory infection, unspecified	0.000	0.998	0.002
Q38.7 Pharyngeal pouch	0.002	0.998	0.000
Q44.6 Cystic disease of liver	0.002	0.998	0.000
D12.8 Rectum	0.002	0.998	0.000
M89.95 Disorder of bone, unspecified (Pelvic region and thigh)	0.002	0.998	0.000
Q61.8 Other cystic kidney diseases	0.002	0.998	0.000
Q61.4 Renal dysplasia	0.002	0.998	0.000
Q61.1 Polycystic kidney, infantile type	0.002	0.998	0.000
S92.50 Fracture of other toe (closed)	0.002	0.998	0.000
C92.9 Myeloid leukaemia, unspecified	0.000	0.998	0.002
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.000	0.998	0.002
C92.7 Other myeloid leukaemia	0.000	0.998	0.002
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.000	0.998	0.002
C92.5 Acute myelomonocytic leukaemia	0.000	0.998	0.002
C92.3 Myeloid sarcoma	0.000	0.998	0.002
C92.2 Subacute myeloid leukaemia	0.000	0.998	0.002
R30 Pain associated with micturition	0.002	0.998	0.000
C92.4 Acute promyelocytic leukaemia	0.000	0.998	0.002
D12 Benign neoplasm of colon, rectum, anus and anal canal	0.002	0.998	0.000
V89.2 Person injured in unspecified motor-vehicle accident, traffic	0.000	0.998	0.002
Y42.7 Androgens and anabolic congeners	0.000	0.998	0.002
J86.9 Pyothorax without fistula	0.002	0.998	0.000
C71.2 Temporal lobe	0.002	0.998	0.000
D61.8 Other specified aplastic anaemias	0.000	0.998	0.002
D61.3 Idiopathic aplastic anaemia	0.000	0.998	0.002
D61.2 Aplastic anaemia due to other external agents	0.000	0.998	0.002
D61.1 Drug-induced aplastic anaemia	0.000	0.998	0.002
D61.0 Constitutional aplastic anaemia	0.000	0.998	0.002
I83.0 Varicose veins of lower extremities with ulcer	0.000	0.998	0.002
M89.99 Disorder of bone, unspecified (Site unspecified)	0.002	0.998	0.000
M89.93 Disorder of bone, unspecified (Forearm)	0.002	0.998	0.000
M89.92 Disorder of bone, unspecified (Upper arm)	0.002	0.998	0.000
M89.91 Disorder of bone, unspecified (Shoulder region)	0.002	0.998	0.000
M89.90 Disorder of bone, unspecified (Multiple sites)	0.002	0.998	0.000
R45.8 Other symptoms and signs involving emotional state	0.002	0.998	0.000
C92.1 Chronic myeloid leukaemia	0.000	0.998	0.002
N93.0 Postcoital and contact bleeding	0.000	0.998	0.002
C71 Malignant neoplasm of brain	0.002	0.998	0.000
Q38 Other congenital malformations of tongue, mouth and pharynx	0.002	0.998	0.000
M89.98 Disorder of bone, unspecified (Other)	0.002	0.998	0.000
C71.1 Frontal lobe	0.002	0.998	0.000
Q61.5 Medullary cystic kidney	0.002	0.998	0.000
Z29.9 Prophylactic measure, unspecified	0.002	0.998	0.000
D12.9 Anus and anal canal	0.002	0.998	0.000
T82.7 Infection and inflammatory reaction due to other cardiac and vascular devices, implants and grafts	0.000	0.998	0.002
M89.96 Disorder of bone, unspecified (Lower leg)	0.002	0.998	0.000
D12.1 Appendix	0.002	0.998	0.000
I49.0 Ventricular fibrillation and flutter	0.002	0.998	0.000
Q44 Congenital malformations of gallbladder, bile ducts and liver	0.002	0.998	0.000
G61.0 Guillain-Barre syndrome	0.002	0.998	0.000
G93.9 Disorder of brain, unspecified	0.002	0.998	0.000
S40.9 Superficial injury of shoulder and upper arm, unspecified	0.002	0.998	0.000
S40.8 Other superficial injuries of shoulder and upper arm	0.002	0.998	0.000
N08.3 Glomerular disorders in diabetes mellitus	0.000	0.998	0.002
Z49.2 Other dialysis	0.000	0.998	0.002
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.998	0.002
M85.89 Other specified disorders of bone density and structure (Site unspecified)	0.002	0.998	0.000
Q61.0 Congenital single renal cyst	0.002	0.998	0.000
S02.8 Fractures of other skull and facial bones	0.000	0.998	0.002
Q05.9 Spina bifida, unspecified	0.002	0.998	0.000
D12.7 Rectosigmoid junction	0.002	0.998	0.000
G55.8 Nerve root and plexus compressions in other diseases classified elsewhere	0.002	0.998	0.000
Z08.7 Follow-up examination after combined treatment for malignant neoplasm	0.002	0.998	0.000
Q38.6 Other congenital malformations of mouth	0.002	0.998	0.000
R30.1 Vesical tenesmus	0.002	0.998	0.000
X49.9 Unspecified place	0.002	0.998	0.000
M89 Other disorders of bone	0.002	0.998	0.000
S92.5 Fracture of other toe	0.002	0.998	0.000
R45.7 State of emotional shock and stress, unspecified	0.002	0.998	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.000	0.998	0.002
G55 Nerve root and plexus compressions in diseases classified elsewhere	0.002	0.998	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.998	0.002
M79.19 Myalgia (Site unspecified)	0.000	0.998	0.002
M89.55 Osteolysis (Pelvic region and thigh)	0.002	0.998	0.000
M89.5 Osteolysis	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations